Cushing’s Shadow: An Overlooked Diagnosis in Endocrinology
Hormone and Metabolic Research · 01.07.2026 · 58 (07) · 253-259
DOI: 10.1055/a-2848-7602 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.07.2026. Verfasst von Lala Soltanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine, Fatih, Turk…. Hauptthemen laut MEDLINE: Pituitary ACTH Hypersecretion, Glucocorticoids, Hydrocortisone. Gefördert von: Ministry of Industry and Technology, Istanbul Development Agency (ISTKA).
Abstract (Originalsprache)
Purpose
The purpose of this study was to describe a novel heterozygous missense variant in the nuclear receptor subfamily 3 group C member 1 ligand-binding domain causing primary generalized glucocorticoid resistance and highlight diagnostic pitfalls that can mimic Cushing’s disease. Clinical case A 22-year-old woman was evaluated for suspected Cushing’s disease after elevated cortisol levels and pituitary imaging findings. She underwent three transsphenoidal surgeries, but hypercortisolism and clinical symptoms including hirsutism, acne, menstrual irregularities, and weight gain persisted. The absence of classical Cushing’s stigmata prompted genetic evaluation, which led to the diagnosis of primary generalized glucocorticoid resistance.
Methods
Whole-exome sequencing was performed in the index case. The identified variant was validated by Sanger sequencing and segregation analysis was carried out in her sister.
Results
A novel heterozygous, likely pathogenic missense variant (NM_000176.3:c.1940T>C, p.(Leu647Pro)) in the nuclear receptor subfamily 3 group C member 1 gene was detected in two siblings.
Conclusions
We describe a novel nuclear receptor subfamily 3 group C member 1 variant associated with primary generalized glucocorticoid resistance, expanding the mutational spectrum of glucocorticoid receptor defects. This case underscores the importance of considering primary generalized glucocorticoid resistance in patients with adrenocorticotropic hormone-dependent hypercortisolism lacking typical Cushing’s features to prevent unnecessary invasive procedures and guide appropriate genetic counseling
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine, Fatih, Turkey.
- Aziz Sancar Institute of Experimental Medicine, Department of Genetics, Istanbul University, Fatih, Turkey.
- Pathology Department, Kocaeli Universitesi Tip Fakultesi, Izmit, Turkey.
ORCID-Profile: Pinar Kadioglu
Förderung
- Ministry of Industry and Technology, Istanbul Development Agency (ISTKA)
Zitieren
APA
Soltanova, L., Sahin, S., Erbilgin, Y., Kocaman, B. B., Muradov, I., Duman, S., Sayitoglu, M., & Kadioglu, P. (2026). Cushing’s Shadow: An Overlooked Diagnosis in Endocrinology. Hormone and Metabolic Research, 58(07), 253-259. https://doi.org/10.1055/a-2848-7602
Vancouver
Soltanova L, Sahin S, Erbilgin Y, Kocaman BB, Muradov I, Duman S, et al. Cushing’s Shadow: An Overlooked Diagnosis in Endocrinology. Hormone and Metabolic Research. 2026;58(07):253-259. doi:10.1055/a-2848-7602
BibTeX
@article{Soltanova2026,
author = {Soltanova, Lala and Sahin, Serdar and Erbilgin, Yucel and Kocaman, Banu Betul and Muradov, Ilkin and Duman, Seda and Sayitoglu, Muge and Kadioglu, Pinar},
title = {Cushing’s Shadow: An Overlooked Diagnosis in Endocrinology},
journal = {Hormone and Metabolic Research},
year = {2026},
volume = {58},
number = {07},
pages = {253--259},
doi = {10.1055/a-2848-7602}
}
EUVIMED